Cargando…

Immunotherapy targeting esophageal cancer stem cells

Detalles Bibliográficos
Autores principales:	Yue, Dongli, Ren, Hongzheng, Huang, Lan, Zhang, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991346/ http://dx.doi.org/10.1186/2051-1426-1-S1-P178

Ejemplares similares

Identification of novel immune checkpoints as targets for cancer immunotherapy
por: Rotman, Galit, et al.
Publicado: (2013)

Identification of novel immune checkpoints as targets for cancer immunotherapy
por: Levy, Ofer, et al.
Publicado: (2014)

A153 PYCRL LACTYLATION AS A POTENTIAL REGULATOR OF CANCER STEM CELL METABOLISM IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
por: Douchin, J, et al.
Publicado: (2023)

Cancer testis antigen expression in triple negative breast cancer: Candidate targets for cancer immunotherapy?
por: Hendrickx, Wouter, et al.
Publicado: (2015)

Cancer-specific T cell receptor isolation for cancer immunotherapy
por: Baker, Debbie Emma, et al.
Publicado: (2015)

Interleukin-4 receptor targeted immunotherapy of human bladder cancer in animal models
por: Joshi, Bharat H, et al.
Publicado: (2014)

Targeting cytomegalovirus (CMV) antigens for GBM immunotherapy
por: Nair, Smita K, et al.
Publicado: (2013)

Safety of targeting ROR1 for cancer immunotherapy with chimeric antigen receptor-modified T cells in a primate model
por: Berger, S Carolina, et al.
Publicado: (2014)

Enhanced natural killer cell targeting of cancer stem cells using Cetuximab
por: Grossenbacher, Steven K, et al.
Publicado: (2014)

Antibody targeted CpG for the immunotherapy of solid tumors
por: Epstein, Alan L, et al.
Publicado: (2015)

Immune suppression by myeloid-derived suppressor cells, MDSCs, in MYCN-driven neuroblastoma provides a potential target for cancer immunotherapy
por: Eissler, Nina, et al.
Publicado: (2014)

EGFR T790M mutation as a novel target for immunotherapy against EGFR-TKI-resistant non-small cell lung cancer
por: Sasada, Tetsuro, et al.
Publicado: (2013)

Brachyury, a driver of tumor invasiveness and resistance to multiple therapies, is a novel immunotherapy target
por: Palena, Claudia, et al.
Publicado: (2013)

Exploitation of gamma delta T cells in cancer immunotherapy as combined antigen-presenters and cancer cell killers
por: Holmen Olofsson, Gitte, et al.
Publicado: (2014)

Tumor-induced suppressive CD8+ T cells: implications for cancer immunotherapy
por: Pfannenstiel, Lukas W, et al.
Publicado: (2013)

Tissue factor-targeted immunotherapy of melanoma and triple negative breast cancer using a second generation ICON
por: Hu, Zhiwei, et al.
Publicado: (2015)

Targeting focal adhesion kinase reprograms the pancreatic tumor microenvironment and renders pancreas cancer responsive to checkpoint immunotherapy
por: Jiang, Hong, et al.
Publicado: (2015)

Monoclonal antibodies targeting cell surface deposited complement fragment C3d potentiate cancer immunotherapy and eliminate antigen loss variants
por: Skarzynski, Martin, et al.
Publicado: (2015)

Engineering the immune response to "self" for effective cancer immunotherapy
por: Zhong, Shi, et al.
Publicado: (2014)

Perioperative volume management for esophageal cancer surgery
por: Ilic, M Karaman, et al.
Publicado: (2013)

ErbB2/HER2-specific NK cells for adoptive cancer immunotherapy
por: Zhang, Congcong, et al.
Publicado: (2013)

Tumor mica status predicts the efficacy of immunotherapy with cytokine-induced killer cells for patients with gastric cancer
por: Chen, Yu, et al.
Publicado: (2015)

Cancer immunotherapy with multiple tumor antigen activated autologous T cells in patients with HBV related hepatocellular carcinoma
por: Han, Yanyan, et al.
Publicado: (2014)

P71. Adoptive transfer of TCR gene-transduced lymphocytes targeting MAGE-A4 for refractory esophageal cancer
por: Shiku, H, et al.
Publicado: (2014)

P14. Cell-based gene delivery leverages conventional immunotherapy for cancer
por: Günther, C, et al.
Publicado: (2014)

Recent advances in adoptive cancer immunotherapy in china
por: Zhou, Juhua
Publicado: (2015)

Targeted temperature management after cardiac arrest and fever control with an esophageal cooling device
por: Hegazy, A, et al.
Publicado: (2015)

Indoleamine 2,3-dioxygenase is a critical resistance mechanism in anti-tumor T cell immunotherapy targeting CTLA-4
por: Holmgaard, Rikke B, et al.
Publicado: (2013)

Lm-LLO immunotherapies targeting multiple antigens and their impact on different mechanisms in the tumor microenvironment
por: Wallecha, Anu, et al.
Publicado: (2014)

T lymphocyte engineering with cytokine nanogels for enhanced cancer immunotherapy
por: Tang, Li, et al.
Publicado: (2015)

Chitosan thermogels for local T lymphocyte delivery for cancer immunotherapy
por: Monette, Anne, et al.
Publicado: (2015)

Expression of cancer-testis antigen in patients with non-small cell lung cancer and its clinical relevance
por: Chen, Xin-Feng, et al.
Publicado: (2013)

T cell receptor affinity and avidity defines antitumor response and autoimmunity in T cell immunotherapy
por: Krogsgaard, Michelle, et al.
Publicado: (2013)

Clinical scale labeling of T cell immunotherapy for MRI cell tracking
por: Helfer, Brooke M, et al.
Publicado: (2015)

Development of novel combinations of targeted and immunotherapies by understanding immune resistance using a high throughput assay of T cell mediated cytotoxicity
por: Malu, Shruti, et al.
Publicado: (2013)

Esophageal cancer in the ICU: a clinical-epidemiological retrospective study
por: de Carvalho, Fabrício RT, et al.
Publicado: (2015)

Intra-patient intra-tumoral immune heterogeneity is evident at progression on targeted therapy and immunotherapy for melanoma
por: Reuben, Alexandre, et al.
Publicado: (2014)

GIFT4-augmented B cells for melanoma immunotherapy
por: Deng, Jiusheng, et al.
Publicado: (2014)

Adoptive immunotherapy for AML with CD123-engager T cells
por: Bonifant, Challice, et al.
Publicado: (2015)

Effect of peep on esophageal catheter optimal calibration volume and esophageal pressure measurements
por: Magni, F, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_321v0crvmqg3c4f4te6shqtju8